MG
PFE icon

Mather Group’s Pfizer PFE Stock Holding History

Mather Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$948K Buy
33,766
+10,994
+48% +$293K 0.01% 343
2025
Q4 		$567K Buy
22,772
+10,363
+84% +$261K 0.01% 384
2025
Q3 		$316K Buy
12,409
+741
+6% +$18.3K ﹤0.01% 504
2025
Q2 		$283K Sell
11,668
-10,517
-47% -$245K ﹤0.01% 516
2025
Q1 		$562K Buy
22,185
+1,978
+10% +$51.8K 0.01% 353
2024
Q4 		$536K Sell
20,207
-4,602
-19% -$125K 0.01% 346
2024
Q3 		$718K Sell
24,809
-25,734
-51% -$751K 0.01% 289
2024
Q2 		$1.4M Buy
50,543
+23,989
+90% +$660K 0.02% 220
2024
Q1 		$764K Sell
26,554
-1,179
-4% -$32.7K 0.01% 263
2023
Q4 		$798K Sell
27,733
-6,436
-19% -$195K 0.01% 261
2023
Q3 		$1.13M Buy
34,169
+8,857
+35% +$313K 0.02% 200
2023
Q2 		$928K Sell
25,312
-10,537
-29% -$410K 0.01% 243
2023
Q1 		$1.46M Sell
35,849
-16,274
-31% -$703K 0.03% 168
2022
Q4 		$2.67M Buy
52,123
+2,709
+5% +$130K 0.05% 120
2022
Q3 		$2.16M Buy
49,414
+7,601
+18% +$369K 0.05% 125
2022
Q2 		$2.19M Buy
41,813
+2,338
+6% +$119K 0.05% 120
2022
Q1 		$2.04M Buy
39,475
+17,910
+83% +$929K 0.04% 108
2021
Q4 		$1.27M Buy
21,565
+6,875
+47% +$341K 0.02% 130
2021
Q3 		$632K Sell
14,690
-386
-3% -$17.1K 0.02% 147
2021
Q2 		$590K Buy
15,076
+163
+1% +$6.34K 0.01% 146
2021
Q1 		$540K Sell
14,913
-677
-4% -$24K 0.02% 142
2020
Q4 		$574K Sell
15,590
-909
-6% -$33.3K 0.02% 126
2020
Q3 		$574K Sell
16,499
-1,076
-6% -$37.7K 0.02% 125
2020
Q2 		$545K Buy
+17,575
New +$597K 0.03% 125

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mather Group's PFE Position: Q1 2026 in Review

Mather Group increased its Pfizer (PFE) stake by 48% in Q1 2026, buying an estimated $293K and bringing the position to 33,766 shares worth $948K. The position accounts for 0.01% of the portfolio, ranked #343.

Mather Group first reported a position in PFE in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.67M in Q4 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mather Group held 33,766 shares of Pfizer worth $948K as of Q1 2026.
  • Mather Group bought 10,994 Pfizer shares in Q1 2026, an estimated $293K.
  • Pfizer made up 0.01% of Mather Group's portfolio in Q1 2026, its #343 holding.
  • Mather Group first reported a position in Pfizer in Q2 2020 and has held it in 24 quarters since.
  • Mather Group's Pfizer position peaked at $2.67M in Q4 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.